Discover
HOWL
Werewolf Therapeutics, Inc.
0.36
5 x 0.35
1 x 0.43
bid
ask
-
0.01
1.36%
1328 @ 04:00 PM
0.37 +0.00 (0.58%)
| Ytd | -42.70% | |
| 1y | -74.07% |
0.36
day range
0.38
0.27
52 week range
2.38
| Open | 0.37 | Prev Close | 0.37 | Low | 0.36 | High | 0.38 | Mkt Cap | 17.64M |
| Vol | 420.38K | Avg Vol | 701.04K | EPS | -1.24 | P/E | -0.29 | Forward P/E | -0.86 |
| Beta | 0.30 | Short Ratio | 2.09 | Inst. Own | 72.62% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 05-07 | 50-d Avg | 0.41 | 200-d Avg | 0.80 | 1yr Est | 12.00 |
| Income Statement | |||
| Operating Expenses | 13.27M | ||
| Research and Development Expense | 8.18M | ||
| Selling, General and Administrative Expense | 5.09M | ||
| Operating Income | -13.27M | ||
| Interest Expense | 1.37M | ||
| Net Income | -13.53M | ||
| Net Income Common Stock | -13.53M | ||
| Net Income Common Stock (USD) | -13.53M | ||
| Consolidated Income | -13.53M | ||
| Earnings per Basic Share | -0.28 | ||
| Earnings per Basic Share (USD) | -0.28 | ||
| Earnings per Diluted Share | -0.28 | ||
| Earning Before Interest & Taxes (EBIT) | -12.16M | ||
| Earning Before Interest & Taxes (USD) | -12.16M | ||
| Weighted Average Shares | 48.60M | ||
| Weighted Average Shares Diluted | 49.39M | ||
| Balance Sheet | |||
| Cash and Equivalents | 46.45M | ||
| Cash and Equivalents (USD) | 46.45M | ||
| Current Assets | 48.73M | ||
| Property, Plant & Equipment Net | 9.29M | ||
| Total Assets | 58.02M | ||
| Debt Current | 30.44M | ||
| Total Debt | 37.65M | ||
| Current Liabilities | 38.52M | ||
| Debt Non-Current | 7.22M | ||
| Total Liabilities | 45.82M | ||
| Accumulated Retained Earnings (Deficit) | -488.94M | ||
| Shareholders Equity | 12.20M | ||
| Shareholders Equity (USD) | 12.20M | ||
| Assets Non-Current | 9.29M | ||
| Total Debt (USD) | 37.65M | ||
| Liabilities Non-Current | 7.30M | ||
| Trade and Non-Trade Payables | 3.57M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 616.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -10.60M | ||
| Net Cash Flow from Operations | -10.60M | ||
| Share Based Compensation | 929.00K | ||